Patents Represented by Attorney Gary M. Lobel
-
Patent number: 8101227Abstract: The present invention is aimed to retain the taste and texture of infant and toddler food products that have been frozen. By employing a slow-churning freezing process, the frozen infant and toddler products are lighter in color, smoother and creamier in texture and possess a better taste profile. The invention further comprises methods of making and using such products.Type: GrantFiled: December 31, 2008Date of Patent: January 24, 2012Assignee: Nestec S.A.Inventor: Leighanne Higgins
-
Patent number: 7989418Abstract: The invention provides an orally-administrable nutritional product comprising a dipeptide including a branched chain amino acid (BCAA). In one embodiment, the nutritional product comprises a dipeptide selected from at least one of the following: alanyl-leucine, alanyl-isoleucine, alanyl-valine, glycyl-leucine, glycyl-isoleucine, and glycyl-valine.Type: GrantFiled: October 26, 2006Date of Patent: August 2, 2011Assignee: Nestec S.A.Inventor: Norman Alan Greenberg
-
Patent number: 7842678Abstract: The present invention concerns compositions comprising a saccharide for the inhibition of pathogen adhesion to mammalian cells.Type: GrantFiled: September 17, 2004Date of Patent: November 30, 2010Assignee: Nestec S.A.Inventors: Jonathan R Rhoades, Robert Rastall, Glenn R. Gibson
-
Patent number: 7794746Abstract: The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhea and constipation.Type: GrantFiled: November 25, 2003Date of Patent: September 14, 2010Assignee: Nestec S.A.Inventors: Glenn R. Gibson, Sofia Kolida
-
Patent number: 7794744Abstract: The present invention relates to a method for preparing an enteral nutrition at the bed of a patient, which involves the use of a standard enteral solution to which is added, via a closed system, one or more compositions in module form, containing selected nutrients, adapted for a specific clinical condition. The present invention also pertains to the different modules, that are preferably in dry form and to the use thereof in the treatment and/or nourishment of a critically ill person.Type: GrantFiled: April 3, 2001Date of Patent: September 14, 2010Assignee: Nestec S.A.Inventors: Olivier Ballevre, Julio Boza, Denis Breuille, Paul-André Finot, Véronique Jaussan, Claudia Roessle, Thomas Schweizer
-
Patent number: 7691906Abstract: A composition for use as a medicament, functional food or nutritional product is described which comprises at least one lipid wherein the lipid provides greater than 35% total energy of the composition. A preferred embodiment comprises a n-6/n-3 fatty acid ratio of about 2/1 to 7/1. In addition, a method of preparing the composition; use of the composition in the manufacture of a medicament, functional food or nutritional product; and a method of treatment or treatment or prevention of sepsis or inflammatory shock which comprises administering an effective amount of the composition are described.Type: GrantFiled: August 16, 2005Date of Patent: April 6, 2010Assignees: Nestec S.A., Institut de la Research AgronomiqueInventors: Marco Turini, Claudia Roessle, Denis Breuille, Gayle Crozier-Willi, Paul André Finot, Myriam Richelle, Guy Dutot, Christiane Obled
-
Patent number: 7678370Abstract: The present invention relates to the use of lactic acid bacteria capable of adhering to the mucosa of the intestine and especially colonizing it for the prevention of peritonitis. In particular, the present invention relates to the use of such lactic acid bacteria for the prevention of peritonitis caused by cirrhosis of the liver. Specifically, the present invention relates to a method for preventing peritonitis in a patient in need of such prevention. This method includes administering to the patient a lactic acid bacterium that is capable of adhering to the intestine's mucosa and essentially colonizing it for the preparation of an ingestable carrier. The invention also relates to a peritonitis preventing composition of a lactic acid bacterium that is capable of adhering to the intestine's mucosa and essentially colonizing it for the preparation of an ingestable carrier. The carrier is preferably a food or pharmaceutical composition.Type: GrantFiled: April 6, 2007Date of Patent: March 16, 2010Assignee: Nestec S.A.Inventors: Eduardo Schiffrin, Carlos Guarner, German Soriano
-
Patent number: 7629442Abstract: The present invention relates to a milk fraction obtainable by acidification of micellar casein and separation from precipitated casein named acid soluble protein from micellar casein. It was found that the milk fraction and especially certain sub-fractions thereof are bioactive and promote GLP-1 release in vitro. Based on these results, acid soluble protein from micellar casein may be useful in the treatment and the prevention of diabetes type II, obesity and may further be added to formulas directed at other purposes addressing the gastro-intestinal tract.Type: GrantFiled: August 30, 2003Date of Patent: December 8, 2009Assignee: Nestec S.A.Inventors: Sandrine Gremlich, Lionel Bovetto, Catherine Mace
-
Patent number: 7585618Abstract: A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum.Type: GrantFiled: April 19, 2005Date of Patent: September 8, 2009Assignee: Nestec S.A.Inventors: Raylene Reimer, Christian Darimont-Nicolau, Katherine Mace, Sandrine Gremlich, Jean-Richard Neeser
-
Patent number: 7482028Abstract: A method of suppressing or curbing appetite and treating or preventing obesity comprising administering to a human or other mammal in need of such treatment an effective amount of plant material derived or derivable from plants of the genera Stapelia and Orbea.Type: GrantFiled: September 19, 2005Date of Patent: January 27, 2009Assignee: Nestec S.A.Inventors: David G Corley, James Miller
-
Patent number: 7468193Abstract: The present invention relates to a nutritional composition suitable for patients undergoing chemotherapy and/or radiation such as cancer patients. The composition, which may be in powder or liquid form, comprises casein and whey proteins, TGF-? and free glutamine.Type: GrantFiled: October 14, 2004Date of Patent: December 23, 2008Assignee: Nestec S.A.Inventors: Eduardo Schiffrin, Denis Breuillé, Stéphanie Blum-Sperisen, Anne Donnet-Hughes, Magali Faure, Claudia Roessle, Marco Enrico Turini
-
Patent number: 7452549Abstract: A source of ?-tocotrienol and/or-tocopherol acts synergistically with an antioxidant source comprising polyphenols, to effect suppression of LDL oxidation in serum. The combination of these two antioxidant sources has wide-ranging applications in treatment of medical conditions arising from free radical generation, including arteriosclerosis and cancer.Type: GrantFiled: October 22, 2001Date of Patent: November 18, 2008Assignee: Nestec S.A.Inventors: Nathalie Hasler-Nguyen, Jacob Zijlstra, John P. Troup
-
Patent number: 7350669Abstract: The present invention relates to a sterile closure device that is particularly suited for flexible containers, or pouches, that contain medical fluids. The sterile closure device provides a port for a conventional spike set to puncture in order to attach a patient feeding line. The sterile closure device features at least two protection mechanisms that enhance sterility. Between the two protection mechanisms is a sterile chamber that minimizes leakage of medical fluid from the flexible container when the protection mechanisms are breached by a the spike set. The sterile closure device also features finger support to facilitate the user in grasping and puncturing the sterile closure device.Type: GrantFiled: September 26, 2003Date of Patent: April 1, 2008Assignee: Novartis AGInventor: Robert G. Rani
-
Patent number: 7125708Abstract: A novel probiotic strain termed Lactobacillus pentosus NCIMB 41114 is capable of preventing growth of pathogenic microorganisms in the GI tract. In particular, this bacterium inhibits Candida overgrowth, and can be employed to prevent and treat associated diseases, including IBS and thrush.Type: GrantFiled: October 11, 2002Date of Patent: October 24, 2006Assignee: University of Reading, School of Food BiosciencesInventors: Anthony G. Wynne, Glenn R. Gibson, Jonathan Brostoff
-
Patent number: 7008648Abstract: A method of suppressing or curbing appetite and treating or preventing obesity comprising administering to a human or other mammal in need of such treatment an effective amount of plant material derived or derivable from plants of the genera Stapelia and Orbea.Type: GrantFiled: November 4, 2002Date of Patent: March 7, 2006Assignee: Novartis Nutrition AGInventors: David Gregory Corley, James Miller
-
Patent number: 6864230Abstract: The present invention is an immunostimulatory composition that bolsters or enhances the immune system in injured, diseased, traumatized or otherwise critically ill patients whose own immune system has been compromised thereby. The ready to feed, liquid formulation comprises glutamine which is stabilized and highly bioavailable in the form of a peptide bound glutamine. Other components comprise the free amino acids such as arginine, a nucleobase such as RNA and omega-3 and omega-6-polyunsaturated fatty acids.Type: GrantFiled: July 19, 2002Date of Patent: March 8, 2005Assignee: Novartis Nutrition AGInventor: Steven M. Ostrom
-
Patent number: RE41159Abstract: The present invention relates to an apparatus for modifying and feeding a liquid nutritional feeding composition. The apparatus comprises a chamber (3) for receiving a beneficial agent for modifying a liquid nutritional feeding composition, the chamber has an inlet (7) connectable to a container (5) that contains the nutritional feeding composition and an outlet (13) connectable to a feeding means (8,9). A pumping means is associated with the chamber (3) for pumping the nutritional feeding composition from the container into the chamber and back into the container to mix the beneficial agent with the nutritional feeding composition before the outlet (13) of the chamber is connected to the feeding means (8,9). The chamber (3) may comprise at least one flexible wall capable of being squeezed and released for pumping the nutritional feeding composition. The invention also relates to a method for modifying and feeding a liquid nutritional feeding composition.Type: GrantFiled: January 21, 1998Date of Patent: March 2, 2010Assignee: Nestec S.A.Inventor: Michel Moreau Bourguignon